← All companies

MDGL

Madrigal Pharmaceuticals, Inc.

MDGL Nasdaq Pharmaceutical Preparations EDGAR ↗

$482.00

-11.11 -2.25%

Key statistics

from XBRL data in SEC filings

Market cap

$11.1B

Revenue (TTM)

$1.28B

Net income (TTM)

-$325M

EPS (TTM)

$-11.28

P/E ratio

—

Dividend yield

—

Free cash flow

-$190M

Cash

$293M

Total assets

$1.24B

Gross margin

—

52-week range

$299.17 – $615.00

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-Q Quarter ended 2026-06-30 Jul 30, 2026 8-K Results of operations (earnings release) Jul 30, 2026 8-K Director or officer change; Shareholder vote results Jun 17, 2026 10-Q Quarter ended 2026-03-31 May 6, 2026 8-K Results of operations (earnings release) May 6, 2026 8-K Director or officer change Apr 28, 2026 10-K Fiscal year ended 2025-12-31 Feb 19, 2026 8-K Results of operations (earnings release) Feb 19, 2026 8-K Entered a material agreement Jan 30, 2026 8-K Director or officer change Dec 11, 2025 10-Q Quarter ended 2025-09-30 Nov 4, 2025 8-K Results of operations (earnings release) Nov 4, 2025 10-Q Quarter ended 2025-06-30 Aug 5, 2025 8-K Results of operations (earnings release) Aug 5, 2025 8-K Regulation FD disclosure Jul 30, 2025 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation; Regulation FD disclosure Jul 22, 2025 8-K Shareholder vote results Jun 20, 2025 10-Q Quarter ended 2025-03-31 May 1, 2025 8-K Results of operations (earnings release) May 1, 2025 8-K Director or officer change Apr 17, 2025 8-K Director or officer change; Regulation FD disclosure Mar 11, 2025 10-K Fiscal year ended 2024-12-31 Feb 26, 2025 8-K Results of operations (earnings release) Feb 26, 2025 8-K Results of operations (earnings release) Jan 13, 2025 10-Q Quarter ended 2024-09-30 Oct 31, 2024 8-K Results of operations (earnings release) Oct 31, 2024 10-Q Quarter ended 2024-06-30 Aug 7, 2024 8-K Results of operations (earnings release) Aug 7, 2024 8-K Director or officer change; Shareholder vote results Jun 27, 2024 8-K Entered a material agreement; Terminated a material agreement; Other events May 7, 2024 10-Q Quarter ended 2024-03-31 May 7, 2024 8-K Results of operations (earnings release) May 7, 2024 8-K Other events Apr 2, 2024 8-K Entered a material agreement Mar 20, 2024 8-K Regulation FD disclosure; Other events Mar 15, 2024 8-K Director or officer change Feb 28, 2024 8-K Results of operations (earnings release) Feb 28, 2024 10-K Fiscal year ended 2023-12-31 Feb 28, 2024 8-K Other events Jan 8, 2024 8-K Results of operations (earnings release) Nov 6, 2023